Subthreshold hyperoxia potentiates TNF-α-induced ICAM-1 expression on cultured pulmonary microvascular endothelial cells

Experimental Lung Research

Volumn 23, Issue 3, 1997, Pages 191-204

  Kiguchi, Toshio ^a   Takahashi, Kimiko ^a   Uwabe, Yasuhide ^b   Nakamura, Hiroyuki ^a   Kashiwabara, Kousuke ^a   Yagyu, Hisanaga ^a   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Hyperoxia; Intercellular adhesion molecule 1 (ICAM 1); Pulmonary microvascular endothelial cells; Tumor necrosis factor alpha (TNF )

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CATTLE; CONTROLLED STUDY; HYPEROXIA; LUNG BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 0030998247     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149709087367     Document Type: Article

References (39)

1. Mulligan MS, Policy MJ, Bayer RJ, Nunn MF, Paulson JG, Ward PA. Neutrophil dependent acute lung injury. J Clin Invest. 1992;90:1600-1607.
2. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care. 1994;9:47-71.
3. Shappell SB, Toman C, Anderson DC, Taylor AA, Entman MN, Smith CW. Mac-1 mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol. 1990;144:2702-2711.
4. Mulligan MS, Varani J, Warren JS, et al. Roles of β2 integrins of rat neutrophils in complement and oxygen radical-mediated acute inflammatory injury. J Immunol. 1992;148:1847-1857.
5. Butcher EC. Leukocyte-endothelial cell recognition. Cell. 1992;57:1033-1036.
6. Fujita H, Morita I, and Murota S. Involvement of adhesion molecules (CD11a-ICAM-1) in vascular endothelial cell injury elicited by PMA-stimulated neutrophils. Biochem Biophys Res Commun. 1991;177:664-672.
7. Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanism. J Clin Invest. 1992;89:981-988.
8. Fujita H, Morita I, Murota S. A possible mechanism for vascular endothelial cell injury elicited by activated leukocytes: a significant involvement of adhesion molecules, CD11/CD18, and ICAM-1. Arch Biochem Biophys. 1994;309:62-69.
9. Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF α, IL-1-β and LPS in human endothelial cells after downregulation of PKC. Am J Physiol. 1992;263: C767-C772.
10. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986;137:245-254.
11. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular adhesion molecule-1 in malignant diseases. Clin Exp Immunol. 1991;85:3-8.
12. Ehlers MRW, Riordan JF. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry. 1991;30:10065-10074.
13. Shijobo N, Imai K, Aoki S, et al. Circulating intercellular adhesion molecule-1 antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol. 1992;89:58-62.
14. Kobayashi T, Hashimoto S, Imai K, et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol. 1994;96:110-115.
15. Takahashi N, Liu MC, Proud D, Yu X, Hasegawa S, Spannhake EW. Soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am J Respir Crit Care Med. 1994;150:704-709.
16. Robertson WG, Hargreaves JJ, Herlocher JE, Welch BE. Physiologic response to increased oxygen partial pressure, II: respiratory studies. Aerospace Med. 1964;35:618-622.
17. Kinnula VL, Mirza Z, Crapo JD, Whorton AR. Modulation of hydrogen peroxide release from vascular endothelial cells by oxygen. Am J Respir Cell Mol Biol. 1993;9:603-609.
18. Kang BH, Crapo JD, Wegner CD, Gordon L, Chang LY. Intercellular adhesion molecule-1 expression on the alveolar epithelium and its modification by hyperoxia. Am J Respir Cell Mol Biol. 1993;9:350-355.
19. Welty SE, Rivera JL, Elliston JF, et al. Increase in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol. 1993;9:393-400.
20. Jornot L, Junod AF. Response of human endothelial cell antioxidant enzymes to hyperoxia. Am J Respir Cell Mol Biol. 1992;6:107-115.
21. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol. 1988;133:426-433.
22. Frank L, Massaro D. Oxygen toxicity. Am J Med. 1980;69:117-126.
23. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-426.
24. Turrens JF, Crapo JD, Freeman BA. Protein against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest. 1984;73:87-95.
25. Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity: early reversible changes in human alveolar structures induced by hyperoxia. New Engl J Med. 1983;309:878-883.
26. Smith LJ. Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. J Lab Clin Med. 1985;106:269-278.
27. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986;133:913-927.
28. Takahashi K, Kiguchi T, Sawasaki Y, et al. Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator. Am Respir Cell Mol Biol. 1992;90-94.
29. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McItyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and neutrophils. J Cell Biol. 1991;112:749-759.
30. Yoshida N, Granger DN, Anderson DC, Rothlein R, Lane C, Kvietys PR. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol. 1992;262:H1891-H1898.
31. Wellicome SM, Thornhill MH, Pitzalis C, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol. 1990;144:2558-2565.
32. Ritchie AJ, Johnson DR, Ewenstein BM, Pober JS. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C. activation or inactivation. J Immunol. 1991;146:3056-3062.
33. Asmuth EJU, Linden CJ, Leeuwenberg JFM, Buurman WA. Involvement of the CD11b/CD18 integrin, but not of the endothelial cell adhesion molecules ELAM-1 and ICAM-1 in tumor necrosis factor-Éø-induced neutrophil toxicity. J Immunol. 1991;147:3869-3875.
34. Zheng H, Crowley JJ, Chan JC, et al. Attenuation of tumor necrosis factor: induced endothelial cell cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis. 1990;142:1073-1078.
35. Nolop KB, Ryan US. Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide. Am J Physiol. 1990;259:L123-L129.
36. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259:1769-1771.
37. Takeda Y, Watanabe H, Yonehara S, Yamashita T, Saito S, Sendo F. Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-Éø. Int Immunol. 1993;5:691-694.
38. O'Brien-Ladner AR, Nelson ME, Cowley BD, Bailey K Jr, Wesselius LJ. Hyperoxia amplifies TNF α production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol. 1995;12: 275-279.
39. 2 toxicity: role of endogenous tumor necrosis factor. Exp Lung Res. 1995;21:589-597.